根据名称进行药物检索

Acetazolamide Sodium 与 Desvenlafaxine

Acetazolamide Sodium 与 Desvenlafaxine互相作用以及同时服用的可能性。

检测结果:

Acetazolamide Sodium <> Desvenlafaxine

现实性: 21.02.2023 评论家: 医学副博士Shkutko P.M., in

在该服务的官方手册中，已注明相关研究结果统计规定的互相作用。该互相作用或对患者健康引起不良后果，或起到良好效果。具体联合用药问题，需遵从医嘱。

用户:

处理与去甲文拉法辛可能会导致血液钠水平太低，这种情况称为血钠和使用与胺可以增加这种风险。你应该寻求医疗照顾，如果你遇到恶心、呕吐、头痛、昏睡、烦躁、注意力难以集中，记忆损伤、混乱、肌肉痉挛、软弱或不稳，因为这些可能的症状低钠血症。更严重的情况下可能导致幻觉，昏厥、扣押、昏迷，甚至死亡。去甲文拉法辛也会影响你的血压和心脏率。你可能需要的剂量调整或更频繁的监测你的血压和脉冲安全地使用这两种药物。你应该避免上升突然从一个坐在或卧位，同时把这些药物，特别是在治疗开始时或之后增加剂量。叫你的医生，如果你遇到头晕、头晕、昏倒，或者一个心跳加速。重要的是要告诉你的医生关于所有其他药物的使用，包括维生素和草药。不停止使用任何药物，没有第一个说你的医生。

医界专家:

监视器：共同给予有利尿剂可以使可能的风险低钠血症相关联的使用选择性的血清素再吸收抑制剂(Ssri)和血清素-去甲肾上腺素再吸收抑制剂(它们). 该机构通过其Ssri和它们产生的血钠还没有明确建立。在许多情况下，血钠似乎是次要的综合症的抗利尿不适当的激素分泌(SIADH). 数情况下，血清钠低于110毫摩尔/升的报道。这些事件一般是可逆的以下中止治疗和/或医疗干预。老年患者和病人服用的剂，或者谁是无卷贫可以在大风险的发展中血钠与Ssri和它们.

监视器：降压药，例如利尿剂有可能促进的直立性效果，这是偶然观察到在启动SSRI或SNRI治疗。晕厥和低血压直立性往往发生在第一周SNRI/SSRI类治疗，但可以在任何时间发生在治疗期间，特别是后一剂量增加。使用Ssri或它们也可能会导致持续增加血压和心脏率，这可能对抗疗效的抗高血压的药物。情况的血压升高，需要立即处理已报告在上市后的经验。

管理：谨慎建议，如果Ssri或它们被规定在与利尿剂，特别是在老年人。病人应被告知寻求医疗注意，如果他们遇到潜在的迹象和症状的血钠，如恶心、呕吐、头痛、不适、昏睡、烦躁、注意力难以集中，记忆损伤、混乱、弱点、肌肉痉挛、和不稳(这可能会导致落). 更严重和/或急情况下可以包括幻觉，晕厥、扣押、昏迷、呼吸逮捕和死亡。停止SSRI/SNRI治疗应视为在患者发展对症血钠和适当的医疗干预的设立是必要的。病人也应该有他们的血压和脉冲监测之前和期间SSRI/SNRI治疗，尤其是在最初的几个星期和下一个剂量增加。病人应当建议避免上升突然从一个坐在或卧位，并通知他们的医生如果他们遇到头晕、头晕、晕厥，orthostasis，或性心动过速。病人也应该避免开车或操作危险机械的直到他们知道如何药物影响到他们。剂量的减少或停药应考虑在病人经历了持续增加血压和脉搏率在SSRI或SNRI治疗。

来源

Jackson C, Carson W, Markowitz J, Mintzer J "SIADH associated with fluoxetine and sertraline therapy." Am J Psychiatry 152 (1995): 809-10
Baliga RR, McHardy KC "Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy [published erratum appears in Br J Clin Pract 1993 May-Jun;47(3):119]." Br J Clin Pract 47 (1993): 62-3
"Product Information. Savella (milnacipran)." Forest Pharmaceuticals, St. Louis, MO.
Cohen BJ, Mahelsky M, Adler L "More cases of SIADH with fluoxetine." Am J Psychiatry 147 (1990): 948-9
Ellison JM, Milofsky JE, Ely E "Fluoxetine-induced bradycardia and syncope in two patients." J Clin Psychiatry 51 (1990): 385-6
Odeh M, Beny A, Oliven A "Severe symptomatic hyponatremia during citalopram therapy." Am J Med Sci 321 (2001): 159-60
Jacob S, Spinler SA "Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults." Ann Pharmacother 40 (2006): 1618-22
Fitzgerald MA "Hyponatremia associated with SSRI use in a 65-year-old woman." Nurse Pract 33 (2008): 11-2
Kessler J, Samuels SC "Sertraline and hyponatremia." N Engl J Med 335 (1996): 524
Feder R "Bradycardia and syncope induced by fluoxetine." J Clin Psychiatry 52 (1991): 139
"Product Information. Effexor (venlafaxine)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Pristiq (desvenlafaxine)." Wyeth Laboratories, Philadelphia, PA.
Rodriguez de la Torre B, Dreher J, Malevany I, et al. "Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients." Ther Drug Monit 23 (2001): 435-40
Pacher P, Kecskemeti V "Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?" Curr Pharm Des 10 (2004): 2463-75
Rosner MH "Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors." Am J Med Sci 327 (2004): 109-11
"Product Information. Cymbalta (duloxetine)." Lilly, Eli and Company, Indianapolis, IN.
Crews JR, Potts NL, Schreiber J, Lipper S "Hyponatremia in a patient treated with sertraline." Am J Psychiatry 150 (1993): 1564
Barclay TS, Lee AJ "Citalopram-associated SIADH." Ann Pharmacother 36 (2002): 1558-63
Doshi D, Borison R "Association of transient SIADH with sertraline." Am J Psychiatry 151 (1994): 779-80
Odeh M, Seligmann H, Oliven A "Severe life-threatening hyponatremia during paroxetine therapy." J Clin Pharmacol 39 (1999): 1290-1
Bouman WP, Johnson H, TrescoliSerrano C, Jones RG "Recurrent hyponatremia associated with sertraline and lofepramine." Am J Psychiatry 154 (1997): 580
"Product Information. Viibryd (vilazodone)." Trovis Pharmaceuticals LLC, New Haven, CT.
"Product Information. Celexa (citalopram)." Forest Pharmaceuticals, St. Louis, MO.
"Product Information. Lexapro (escitalopram)." Forest Pharmaceuticals, St. Louis, MO.
"Product Information. Zoloft (sertraline)." Roerig Division, New York, NY.
Spigset O, hedenmalm K "Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions." Pharmacotherapy 17 (1997): 348-52
"Product Information. Fetzima (levomilnacipran)." Forest Pharmaceuticals, St. Louis, MO.
Staab JP, Yerkes SA, Cheney EM, Clayton AH "Transient SIADH associated with fluoxetine." Am J Psychiatry 147 (1990): 1569-70
Madhusoodanan S, Brenner R, Brafman I, Bogunovic O "Hyponatremia associated with paroxetine use." South Med J 92 (1999): 843
Andrews C, Pinner G "Postural hypotension induced by paroxetine." BMJ 316 (1998): 595
Llorente MD, Gorelick M, Silverman MA "Sertraline as the cause of inappropriate antidiuretic hormone secretion." J Clin Psychiatry 55 (1994): 543-4
Robinson D, Brooks J, Mahler E, Sheikh JI "SIADH--compulsive drinking or SSRI influence?" Ann Pharmacother 30 (1996): 885
Blacksten JV, Birt JA "Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine." Ann Pharmacother 27 (1993): 723-4
Esposito P, Rampino T, Gregorini M, et al. "Severe symptomatic hyponatremia during sibutramine therapy: a case report." Am J Kidney Dis 52 (2008): 137-9
Hwang AS, Magraw RM "Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine." Am J Psychiatry 146 (1989): 399
Spier SA, Frontera MA "Unexpected deaths in depressed medical inpatients treated with fluoxetine." J Clin Psychiatry 52 (1991): 377-82
"Product Information. Prozac (fluoxetine)." Dista Products Company, Indianapolis, IN.
Vishwanath BM, Navalgund AA, Cusano W, Navalgund KA "Fluoxetine as a cause of SIADH." Am J Psychiatry 148 (1991): 542-3
Ayonrinde OT, Sanfilippo FM "SSRI antidepressants and SIADH." Aust N Z J Psychiatry 31 (1997): 306-7
Kazal LA, Jr Hall DL, Miller LG, Noel ML "Fluoxetine-induced SIADH: a geriatric occurrence?" J Fam Pract 36 (1993): 341-3
Ayonrinde OT, Reutens SG, Sanfilippo FM "Paroxetine-induced SIADH." Med J Aust 163 (1995): 390
Chua TP, Vong SK "Hyponatraemia associated with paroxetine." BMJ 306 (1993): 143
"Product Information. Paxil (paroxetine)." GlaxoSmithKline, Research Triangle Park, NC.
van Campen JP, Voets AJ "SIADH caused by paroxetine." Ann Pharmacother 30 (1996): 1499
Woo MH, Smythe MA "Association of SIADH with selective serotonin reuptake inhibitors." Ann Pharmacother 31 (1997): 108-10
Girault C, Richard JC, Chevron V, Goulle JP, Droy JM, Bonmarchand G, Leroy J "Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine." J Toxicol Clin Toxicol 35 (1997): 93-5
Bradley ME, Foote EF, Lee EN, Merkle L "Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature." Pharmacotherapy 16 (1996): 680-3
Thornton SL, Resch DS "SIADH associated with sertraline therapy." Am J Psychiatry 152 (1995): 809
"Selective serotonin reuptake inhibitors and SIADH." Med J Aust 164 (1996): 562
Goddard C, Paton C "Hyponatraemia associated with paroxetine." BMJ 305 (1992): 1332
"Product Information. Brintellix (vortioxetine)." Takeda Pharmaceuticals America, Lincolnshire, IL.
Covyeou JA, Jackson CW "Hyponatremia associated with escitalopram." N Engl J Med 356 (2007): 94-5
"Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc, Marietta, GA.
Schattner A, Skurnik Y "Fluoxetine-induced SIADH." J Am Geriatr Soc 44 (1996): 1413